Patents by Inventor Rie Sasaki

Rie Sasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNAPSE FORMATION AGENT
    Publication number: 20240122988
    Abstract: The present invention relates to a synapse formation promoter and a brain plasticity promoter comprising CD24-negative mesenchymal stem cells prepared from a patient's own bone marrow aspirate and treatment of dementia, chronic-phase cerebral infarction, chronic-phase spinal cord injury, mental diseases, and the like using the synapse formation promoter and brain plasticity promoter.
    Type: Application
    Filed: April 26, 2023
    Publication date: April 18, 2024
    Applicants: Sapporo Medical University, Nipro Corporation
    Inventors: Osamu Honmou, Masanori Sasaki, Rie Maezawa, Shinichi Oka, Yuko Sasaki, Masahito Nakazaki, Toshihiko Yamashita
  • Therapeutic agent or preventive agent for alopecia areata
    Patent number: 10881649
    Abstract: A therapeutic agent or a preventive agent for alopecia areata has an ROR? antagonistic activity, and, there is a therapeutic agent or a preventive agent for alopecia areata, including a cyclic amine derivative typified by the following compound or a pharmacologically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: January 5, 2021
    Assignee: Toray Industries, Inc.
    Inventors: Rie Sasaki, Shinnosuke Hayashi, Martial Vallet, Shinya Yokosaka, Kazuya Osumi, Takumi Aoki, Hiroyuki Meguro, Mie Kaino, Kozue Takagaki, Takehiro Takahashi
  • CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF
    Publication number: 20200392107
    Abstract: A cyclic amine derivative represented by general Formula (I): wherein R1 represents an alkyl group having 1 to 3 carbon atoms; A represents a group represented by general Formula (II-1), (II-2), or (II-3): R2 represents a hydrogen atom or a halogen atom; R3 represents an aryl group or a cycloalkyl group having 4 to 6 carbon atoms, wherein any 1 or 2 hydrogen atoms of the aryl or cycloalkyl group represented by R3 may be each independently substituted with an alkyl group having 1 to 3 carbon atoms or an alkyloxy group having 1 to 3 carbon atoms, and wherein any 1 to 3 hydrogen atoms of the alkyl or alkyloxy group having 1 to 3 carbon atoms which can be a substituent of the aryl or cycloalkyl group may be each independently substituted with a halogen atom; n represents 1 or 2; or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: January 30, 2019
    Publication date: December 17, 2020
    Inventors: Kazuya Osumi, Yuki Matsumura, Shinnosuke Hayashi, Masaki Hoshi, Martial Vallet, Shinya Yokosaka, Takumi Aoki, Hiroyuki Meguro, Mie Kaino, Kozuc Takagaki, Rie Sasaki
  • THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR ALOPECIA AREATA
    Publication number: 20200215046
    Abstract: A therapeutic agent or a preventive agent for alopecia areata has an ROR? antagonistic activity, and, there is a therapeutic agent or a preventive agent for alopecia areata, including a cyclic amine derivative typified by the following compound or a pharmacologically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: July 27, 2018
    Publication date: July 9, 2020
    Inventors: Rie Sasaki, Shinnosuke Hayashi, Martial Vallet, Shinya Yokosaka, Kazuya Osumi, Takumi Aoki, Hiroyuki Meguro, Mie Kaino, Kozue Takagaki, Takehiro Takahashi
  • C-C chemokine synthesis inhibitor
    Patent number: 6653345
    Abstract: A method of inhibiting mammalian C—C chemokine production by using a mammalian C—C chemokine synthesis inhibitor containing a prostaglandin I derivative as an active component to treat a variety of circulatory diseases, inflammation, allergic diseases, and renal diseases.
    Type: Grant
    Filed: May 6, 2002
    Date of Patent: November 25, 2003
    Assignee: Toray Industries, Inc.
    Inventors: Hajimu Kurumatani, Rie Sasaki, Hiroki Kumagai
  • C-C chemokine synthesis inhibitor
    Publication number: 20020193427
    Abstract: The present invention relates to a C—C chemokine production inhibitor containing a prostanoic acid derivative as an active component, and a method of inhibiting C—C chemokine production by using the inhibitor. Medicines of the present invention are effective to cure circulatory diseases, inflammation, allergic diseases, renal diseases, etc.
    Type: Application
    Filed: May 6, 2002
    Publication date: December 19, 2002
    Applicant: Toray Industries, Inc.
    Inventors: Hajimu Kurumatani, Rie Sasaki, Hiroki Kumagai